Brits planning international travel are being alerted to a significant increase in yellow fever cases, a potentially fatal mosquito-borne viral disease. Recent data indicates a fivefold rise in reported cases in 2025 compared to the previous year, prompting updated travel advisories for destinations in Africa and the Americas. Yellow fever poses a risk in specific regions of Africa, Central and South America, and Trinidad in the Caribbean, transmitted through the bite of infected mosquitoes.
The amplified concern stems from a detailed report by Travel Health Pro, highlighting a substantial surge in yellow fever incidence across South and Central America. In 2025, this region documented 346 confirmed human cases, tragically resulting in 143 deaths across seven countries. This figure represents a stark 5.6-fold increase from the preceding year. As of early 2026, an additional 41 confirmed cases, including 18 fatalities, have been reported from Bolivia, Colombia, Peru, and Venezuela, underscoring the persistent and evolving threat.
Yellow Fever Incidence and Geographic Spread
The majority of yellow fever cases in 2024 were concentrated in the Amazon region. However, the disease's footprint has expanded significantly. Travel Health Pro notes that cases are now being reported in broader geographical areas beyond the Amazon basin. Notably, this includes occurrences in Sao Paulo State, Brazil, and Tolima Department in Colombia. Furthermore, recent human yellow fever cases in Venezuela have emerged in areas previously not considered to be at risk, indicating a concerning shift in disease distribution.
The risk of yellow fever outbreaks in South America remains elevated. Colombia, in particular, has been experiencing an ongoing outbreak since mid-2024, with 153 confirmed cases and 62 deaths reported. The confirmation of yellow fever cases across a wider geographical area, coupled with reports of jungle transmission near urban centers, substantially heightens the risk of large-scale urban outbreaks. Such scenarios could lead to rapid and widespread dissemination of the virus.
African Yellow Fever Risk Factors
The threat of yellow fever transmission also persists in endemic regions of Africa. The mosquitoes responsible for transmitting the virus are prevalent in many urban areas across the continent. This widespread presence of vectors in densely populated settings significantly increases the potential for the rapid spread of yellow fever, leading to widespread outbreaks. The interconnectedness of travel routes means that localized outbreaks can quickly escalate into regional health concerns.
The situation necessitates heightened vigilance from travelers and public health authorities alike. Understanding the endemic zones, transmission patterns, and the efficacy of preventive measures is crucial for mitigating the impact of this disease. The dynamic nature of yellow fever's spread requires continuous monitoring and updated guidance for international travelers to ensure their safety and well-being.
Recommendations for Travelers
Individuals planning to travel to at-risk countries are strongly advised to consult official travel health resources to assess their specific risk for yellow fever. This includes reviewing vaccine recommendations and any certificate requirements mandated by their destination country. The TravelHealthPro Country Information pages serve as a primary resource for such guidance.
Vaccination against yellow fever is recommended for all travelers aged nine months and older visiting areas with a known risk of transmission, provided there are no medical contraindications. Some nations may require an International Certificate of Vaccination or Prophylaxis (ICVP) as proof of vaccination for entry. It is important for travelers to understand that even if a country does not officially require a yellow fever ICVP, the risk of exposure may still exist, making vaccination a vital personal protection measure.
Vaccination and Prevention Strategies
The yellow fever vaccine is not provided free of charge through the National Health Service (NHS) in the UK and typically incurs a cost ranging from £60 to £85. Travelers can locate nearby vaccination centers through online directories. In addition to vaccination, diligent adherence to mosquito bite avoidance strategies is paramount. These measures include using effective insect repellents, wearing protective clothing, and sleeping in screened or air-conditioned accommodations to minimize exposure.
Symptoms of yellow fever typically manifest three to six days after an infected mosquito bite, although the incubation period can sometimes be longer. Initial symptoms often resemble those of influenza, including a high temperature, headache, nausea, body aches, loss of appetite, and a general feeling of malaise. These early symptoms usually subside within three to four days.
Recognizing Severe Yellow Fever Symptoms
A small percentage of individuals infected with yellow fever may develop a more severe form of the illness approximately 24 hours after initial symptom resolution. This severe stage is characterized by more critical health indicators. Prominent among these is jaundice, a yellowing of the skin and eyes, accompanied by dark urine due to impaired liver function.
Additional severe symptoms include abdominal pain, and potentially life-threatening bleeding. This bleeding can occur from the eyes, nose, mouth, or gastrointestinal tract, sometimes manifesting as blood in vomit or stool. The NHS emphasizes that these advanced symptoms can be fatal. Anyone experiencing these severe symptoms after traveling to a yellow fever-endemic region should seek urgent medical attention, either from a General Practitioner (GP) or by contacting NHS 111 for immediate guidance.
